A fat-derived protein known for its effects on the liver and skeletal muscle might also serve as an energy-conserving signal to the brain during periods of starvation, suggests a new study.
Cancer Biomarkers Market Size To Reach USD 48 20 Billion&Nbsp; By 2026 menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
According to Fortune Business Insights, The Biomarkers Market size is anticipated to reach USD 97.51 Billion by 2026, the market size was USD 39.10 billion.
Share:
Pune, India, March 03, 2021 (GLOBE NEWSWIRE) The global
plasma fractionation market size is expected to reach USD 48.55 billion by 2027, exhibiting a CAGR of 7.6% during the forecast period. The growing incidence of immunological disorders is expected to spur demand for the market, states Fortune Business Insights, in a report, titled Plasma Fractionation Market Size, Share & COVID-19 Impact Analysis, By Product (Immunoglobulin, Albumin, Coagulation Factors, Protease Inhibitors, and Others), By Application (Immunology & Neurology, Hematology, Critical Care, Pulmonology, and Others), By End-user (Hospitals & Clinics, Clinical Research Laboratories, and Others), and Regional Forecast, 2020-2027. The market size stood at USD 25.44 billion in 2019.
Notable Development:
Dermal Fillers Market Size worth USD 6.64 Billion by 2027 at 9.3% CAGR; High Demand for Minimally Invasive Surgeries to Boost Growth: Fortune Business Insights™ Top Players Covered in the Dermal Fillers market Research Report Are ALLERGAN (Dublin, Ireland), Revance Therapeutics, Inc. (California, U.S.), Merz Pharma (Frankfurt, Germany), Galderma (Lausanne, Switzerland), Sinclair Pharma (London, U.K.), Sun Pharmaceutical Industries Ltd (Mumbai, India), BIOPLUS CO., LTD. (South Korea), Bioxis Pharmaceuticals (Lyon, France), SCULPT Luxury Dermal Fillers LTD (U.K.), DR. Korman (Kiryat Bialik, Israel), Prollenium Medical Technologies (Toronto, Canada), Suneva Medical (California, U.S.), Anika Therapeutics, Inc. (Massachusetts, U.S.) and other key market players.